90366-30-6

Usage

Uses

Used in Pharmaceutical Industry:
3,4,5,6-TETRA-O-ACETYL-MYO-INOSITOL is used as a synthetic intermediate for the production of pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Chemical Research:
3,4,5,6-TETRA-O-ACETYL-MYO-INOSITOL is used as a research compound in the field of organic chemistry. It provides chemists with a versatile starting material for the synthesis of complex organic molecules and the exploration of novel chemical reactions.
Used in the Synthesis of Myo-Inositol Ferulic Acid Ester Derivatives:
3,4,5,6-TETRA-O-ACETYL-MYO-INOSITOL is used as a key component in the synthesis of seven novel myo-inositol ferulic acid ester derivatives. These derivatives exhibit potential biological activities and may have applications in various industries, such as pharmaceuticals, cosmetics, and food additives.

InChI:InChI=1/C14H20O10/c1-5(15)21-11-9(19)10(20)12(22-6(2)16)14(24-8(4)18)13(11)23-7(3)17/h9-14,19-20H,1-4H3

Upstream product

• 87-89-8 D-myo-inositol 
• 4136-18-9 1⁽³⁾,2-di-O-(2-tetrahydropyranyl)-3⁽¹⁾-4⁽⁶⁾,5,6⁽⁴⁾-tetra-O-acetyl-sn-myoinositol 
• 76690-10-3 2-O-(2-tetrahydropyranyl)-1⁽³⁾,4⁽⁶⁾,5,6⁽⁴⁾-tetra-O-acetyl-sn-myoinositol 
• 76690-10-3 1⁽³⁾-O-(2-tetrahydropyranyl)-3⁽¹⁾,4⁽⁶⁾,5,6⁽⁴⁾-tetra-O-acetyl-sn-myoinositol 
• 39110-61-7 3,4,5,6-tetra-O-acetyl-1,2-O-cyclohexylidene-myo-inositol 
• 6763-47-9 rac-1,2-O-cyclohexylidene-myo-inositol 

Downstream Products

• 29971-56-0 3-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-1,4,5,6-tetra-O-acetyl-sn-myo-inositol 
• 29971-56-0 1-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-3,4,5,6-tetra-O-acetyl-sn-myo-inositol 
• 80065-84-5 1(3)-O-β-benzoylpropionyl-3(1),4(6),5,6(4)-tetra-O-acetyl-sn-myoinositol 
• 35427-05-5 3,4,6-tri-O-acetyl-1,2-O-(3,4,5,6-tetra-O-acetyl-sn-myoinositol-1-orthoacetyl)-β-D-mannopyranose 
• 35427-05-5 3,4,6-tri-O-acetyl-1,2-O-(1,4,5,6-tetra-O-acetyl-sn-myoinositol-3-orthoacetyl)-β-D-mannopyranose 
• 29971-56-0 2-O-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-1(3),4(6),5,6(4)-tetra-O-acetyl-sn-myo-inositol 
• 29971-56-0 3-O-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-1,4,5,6-tetra-O-acetyl-sn-myo-inositol 
• 29971-56-0 1-O-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-3,4,5,6-tetra-O-acetyl-sn-myo-inositol 
• 6931-62-0 (+/-)-1,4,5,6-Tetra-O-acetyl-3-O-mesyl-myo-inosit 
• 5160-25-8 1,3,4,5,6-Penta-O-acetyl-2-O-methansulfonyl-myo-inosit 
• 52389-41-0 1(3),3(1),4(6),5,6(4)-penta-O-acetyl-sn-myoinositol 
• 20021-56-1 DL-(1,3/2,4)-1,2,3,4-Tetra-O-acetylcyclohexanetetrol 
• 6730-18-3 Pentaacetyl-1-azido-1-deoxy-scyllo-inosit 
• 135346-51-9 Acetic acid (1S,2S,5R,6S)-5,6-diacetoxy-2-(2,2-dimethyl-4,6-dioxo-[1,3]dioxan-5-yl)-cyclohex-3-enyl ester 

Relevant academic research and scientific papers

COMPOUNDS AND COMPOSITIONS FOR THE DETECTION AND TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS

One aspect of the present invention relates to compounds, compositions and methods for diagnosis and/or treatment of a subject suffering from an amyloidosis-associated pathological condition. In certain embodiments, the imaging and/or therapeutic agents of the instant invention may be administered to a subject for identification and/or treatment of amyloid deposits. A specific imaging method detects amyloid deposits by administering the imaging agent to the subject and detecting the spatial distribution of the agent. Differential accumulation of the agent is indicative of AD or an amyIoidosis-associated pathological condition and can be monitored by using a PET or SPECT camera.

SYNTHESIS OF BRANCHED-CHAIN CYCLITOLS USING A PALLADIUM(0)-CATALYZED ALLYLIC COUPLING REACTION

A carbanion derived from Meldrum's acid was used in a palladium(0)-catalysed allylic substitution reaction to prepare stereospecifically branched-chain cyclitols from the symmetrical 1,2,3,4-tetraacetoxycyclohex-5-ene (4).

INVESTIGATIONS IN THE FIELD OF ASYMMETRICALLY SUBSTITUTED MYOINOSITOL DERIVATIVES. XXX. REACTION OF 2,3-DIHYDROPYRAN WITH TETRASUBSTITUTED DERIVATIVES OF MYOINOSITOL

In the reaction of 2,3-dihydropyran with 1(3),4(6),5,6(4)-tetra-O-benzyl- and 1(3),4(6),5,6(4)-tetra-O-acetyl-sn-myoinositols the corresponding mono- and ditetrahydropyranyl ethers are formed.